ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness of the potentially serious health consequences of untreated SDB.
ResMed was founded in 1989 to develop a new treatment for an old, but largely unknown disease called sleep apnea. In pioneering successful SDB treatment, ResMed has opened up a new field of scientific study. Knowledge of this disorder and its treatment continues to develop as governments and health insurers better understand the enormous benefit treatment offers, not just in the improved lives of patients, but to their own bottom lines.
ResMed's products include continuous, automatic and variable positive airway pressure (CPAP, APAP and VPAP) therapy devices and non-invasive ventilation systems built on the award-winning S9™ Series platform, a sleek, compact device that is both user-friendly and ultra-quiet, as well as mandibular repositioning — or dental — devices for treating mild to moderate sleep apnea. ResMed also provides market-leading masks that combine superior performance and comfort with ease of use.